The most important potential is being missed here21 Jul 2022 13:11
Enormous potential, imo.
The analysis of Virus Like Particles (VLPs) is a further application of Paraytec's technology. VLP's are a key technology used to deliver treatments in the rapidly growing market for gene therapy medicine. These VLPs are capsids (very small biological capsules) and are used to carry a modified DNA that will perform the gene therapy, into a patient's body. Critical to patient safety is the quality control of these VLPs. However, current analytical methods are not well suited to testing these materials during all the stages of VLP manufacture. Paraytec is now building a modified CX300 instrument to show that its new technology can be used to detect the ratio of full/empty capsids, a critical quality attribute to be determined both during production and following purification. Paraytec is working with FUJIFILM Diosynth Biotechnologies and the UK's Cell and Gene Therapy Catapult on a collaborative proposal for development of our instrumentation and comparing performance with current analytical methods during manufacturing runs.